Elvian Labs
Elvian Labs
Stealth ModeElvian Labs is a UK-based startup developing AI-powered solutions for the healthcare sector, focusing on medical imaging and diagnostics.
About
What does Elvian Labs do?
Elvian Labs specializes in creating artificial intelligence tools to enhance medical imaging analysis and improve diagnostic accuracy. Their solutions aim to assist healthcare professionals in identifying diseases earlier and more efficiently, ultimately leading to better patient outcomes.
Where is Elvian Labs headquartered?
Elvian Labs is headquartered in London, United Kingdom.
When was Elvian Labs founded?
Elvian Labs was founded in 2026.
What industry does Elvian Labs operate in?
Elvian Labs operates in HealthTech, MedTech, Medical Imaging, Diagnostics, Computer Vision, AI Tool.
What is Elvian Labs's current status?
Elvian Labs's current operating status is: Inactive.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
AI-powered platform for personalized weight management and health coaching.
Clinical Trial Discovery by ENSCORE.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.